Weiguo Zhu

972 total citations
30 papers, 780 citations indexed

About

Weiguo Zhu is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiguo Zhu has authored 30 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiguo Zhu's work include Esophageal Cancer Research and Treatment (9 papers), MicroRNA in disease regulation (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Weiguo Zhu is often cited by papers focused on Esophageal Cancer Research and Treatment (9 papers), MicroRNA in disease regulation (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Weiguo Zhu collaborates with scholars based in China and United States. Weiguo Zhu's co-authors include Ray B. Nagle, Anne E. Cress, Isaac Rabinovitz, Xi‐Lei Zhou, Guangzhou Tao, Changhua Yu, Wanwei Wang, Yu‐Suo Tong, Yaqi Song and Peng Pan and has published in prestigious journals such as Scientific Reports, Carbohydrate Polymers and Experimental Cell Research.

In The Last Decade

Weiguo Zhu

29 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiguo Zhu China 15 405 290 212 190 154 30 780
Shigemasa Suzuki Japan 16 335 0.8× 205 0.7× 155 0.7× 187 1.0× 226 1.5× 48 745
Zuli Yang China 18 442 1.1× 224 0.8× 290 1.4× 297 1.6× 176 1.1× 44 963
Dianyun Ren China 16 419 1.0× 202 0.7× 261 1.2× 141 0.7× 69 0.4× 25 708
Shuya Hirao Japan 12 426 1.1× 124 0.4× 168 0.8× 109 0.6× 148 1.0× 24 689
Jose Juarez United States 10 377 0.9× 422 1.5× 246 1.2× 76 0.4× 60 0.4× 15 747
Go Masuda Japan 15 354 0.9× 188 0.6× 215 1.0× 114 0.6× 74 0.5× 35 632
Jeffery N. Myers United States 11 385 1.0× 184 0.6× 263 1.2× 122 0.6× 136 0.9× 14 723
Gui Ren China 18 712 1.8× 546 1.9× 263 1.2× 220 1.2× 180 1.2× 39 1.1k
H. Fujimoto Japan 10 356 0.9× 107 0.4× 149 0.7× 166 0.9× 96 0.6× 19 605
Xue‐cheng Bi China 15 383 0.9× 160 0.6× 216 1.0× 165 0.9× 94 0.6× 30 667

Countries citing papers authored by Weiguo Zhu

Since Specialization
Citations

This map shows the geographic impact of Weiguo Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Zhu more than expected).

Fields of papers citing papers by Weiguo Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiguo Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Zhu. The network helps show where Weiguo Zhu may publish in the future.

Co-authorship network of co-authors of Weiguo Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiguo Zhu. A scholar is included among the top collaborators of Weiguo Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiguo Zhu. Weiguo Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Yingying, Xi‐Lei Zhou, Changhua Yu, et al.. (2021). Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy. Frontiers in Oncology. 11. 655071–655071. 9 indexed citations
3.
Zhu, Weiguo, et al.. (2020). Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer. Bioengineered. 11(1). 932–938. 38 indexed citations
4.
Tong, Yu‐Suo, Lili Yang, Changhua Yu, et al.. (2020). Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs. Molecular Therapy — Oncolytics. 18. 1–13. 73 indexed citations
5.
Zhou, Leilei, Jie Ni, Wanting Feng, et al.. (2017). High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma. Experimental Cell Research. 361(1). 126–134. 31 indexed citations
6.
Zhou, Xi‐Lei, Yongqiang Li, Weiguo Zhu, et al.. (2017). Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Scientific Reports. 7(1). 42581–42581. 43 indexed citations
7.
Han, Jun, et al.. (2016). Prognostic value of microRNA-126 and CRK expression in gastric cancer. OncoTargets and Therapy. Volume 9. 6127–6135. 13 indexed citations
8.
Jin, Peng, et al.. (2016). Bile acids cycle disruption in patients with nasopharyngeal carcinoma promotes the elevation of interleukin-10 secretion. African Health Sciences. 15(4). 1200–1200. 1 indexed citations
9.
10.
Song, Yaqi, Wanwei Wang, Guangzhou Tao, et al.. (2015). Survival benefit of radiotherapy to patients with small cell esophagus carcinoma - an analysis of Surveillance Epidemiology and End Results (SEER) data. Oncotarget. 7(13). 15474–15480. 8 indexed citations
11.
12.
Pu, Juan, Shanshan Qin, Yan Zhang, et al.. (2013). A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery. Journal of Cancer Research and Clinical Oncology. 139(4). 703–708. 20 indexed citations
13.
Dai, Ping, Bo Song, Xu Chen, et al.. (2012). Apoptosis-induced anti-tumor effect of Curcuma kwangsiensis polysaccharides against human nasopharyngeal carcinoma cells. Carbohydrate Polymers. 89(4). 1067–1072. 30 indexed citations
14.
15.
Ji, Jian, et al.. (2012). JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma. Clinical & Translational Oncology. 14(2). 143–149. 42 indexed citations
16.
Zhu, Weiguo, Guangzhou Tao, Tao Li, et al.. (2011). Effects of postoperative 3-dimensional conformal radiotherapy on lymph node positive patients after radical resection of esophageal carcinoma. Zhonghua fangshe yixue yu fanghu zazhi. 31(5). 571–574. 1 indexed citations
17.
Yu, Changhua, Ren Yu, Weiguo Zhu, Yaqi Song, & Tao Li. (2011). Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery. Journal of Cancer Research and Clinical Oncology. 138(2). 255–259. 38 indexed citations
18.
Zhu, Weiguo, et al.. (2011). Prognostic value of ADAM17 in human gastric cancer. Medical Oncology. 29(4). 2684–2690. 28 indexed citations
19.
Guo, Wei, et al.. (2010). Extrapleural Nuss procedure for the correction of pectus excavatum under choledochoscope. 9(3). 200–202. 1 indexed citations
20.
Cress, Anne E., Isaac Rabinovitz, Weiguo Zhu, & Ray B. Nagle. (1995). The ?6?1 and ?6?4 integrins in human prostate cancer progression. Cancer and Metastasis Reviews. 14(3). 219–228. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigemasa Suzuki Breakdown of academic impact, for papers by Zuli Yang Breakdown of academic impact, for papers by Dianyun Ren Breakdown of academic impact, for papers by Shuya Hirao Breakdown of academic impact, for papers by Jose Juarez Breakdown of academic impact, for papers by Go Masuda Breakdown of academic impact, for papers by Jeffery N. Myers Breakdown of academic impact, for papers by Gui Ren Breakdown of academic impact, for papers by H. Fujimoto Breakdown of academic impact, for papers by Xue‐cheng Bi
Rankless by CCL
2026